Related Experiment Video

Updated: Jun 4, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

Activation of K-RAS by co-mutation of codons 19 and 20 is transforming

Adam Naguib1, Catherine H Wilson, David J Adams

  • 1Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ, UK. mja40@cam.ac.uk.

Journal of Molecular Signaling
|March 5, 2011
PubMed

Insights

A novel K-RAS co-mutation (L19F/T20A) in colorectal cancer showed intermediate transforming ability. This finding highlights the functional significance of co-mutations in K-RAS signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The K-RAS oncogene is frequently mutated in human cancers, driving tumor growth.
  • Activating K-RAS mutations lead to uncontrolled cell signaling via MAPK/ERK and PI3K/AKT pathways.
  • Most K-RAS mutations occur at codons 12 and 13, crucial for its oncogenic function.

Purpose of the Study:

  • To investigate a novel K-RAS co-mutation identified in colorectal cancer.
  • To determine the functional significance and transforming ability of this co-mutation.
  • To explore the synergistic effects of mutations at codons 19 and 20.

Main Methods:

  • Identification of a novel K-RAS co-mutation (L19F/T20A) in a human colorectal cancer sample.
  • In vitro focus-forming transformation assays to assess cellular transforming ability.
  • Comparison of the transforming potential of the novel co-mutation against individual mutants and known activating mutants (G12D, G12V).

Main Results:

  • The K-RAS L19F/T20A co-mutation exhibited intermediate transforming ability.
  • This co-mutation demonstrated greater transforming potential than individual L19F or T20A mutations.
  • The transforming ability was less potent than established K-RAS mutants like G12D and G12V.

Conclusions:

  • Co-mutation of K-RAS codons 19 and 20 (L19F/T20A) has functional significance in cancer development.
  • Synergistic effects were observed between mutations at codons 19 and 20, influencing K-RAS signaling.
  • This study expands the understanding of K-RAS mutation landscape and its oncogenic impact.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...